{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:05:41Z","timestamp":1792130741346,"version":"4.4.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","award":["UCLA MIMG M. John Pickett Post-Doctoral Fellow Award"],"award-info":[{"award-number":["UCLA MIMG M. John Pickett Post-Doctoral Fellow Award"]}],"id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"DOI":"10.1186\/s13045-026-01822-6","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T19:24:24Z","timestamp":1782933864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Large language model-guided CAR-T in silico platform for cytokine optimization in liver cancer with low antigen density"],"prefix":"10.1186","volume":"19","author":[{"given":"Haochen","family":"Nan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youcheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ruide","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"1822_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","volume":"17","author":"S Rafiq","year":"2020","unstructured":"Rafiq S, Hackett CS, Brentjens RJ. Engineering strategies to overcome the current roadblocks in CAR T cell therapy. Nat Rev Clin Oncol. 2020;17:147\u201367.","journal-title":"Nat Rev Clin Oncol"},{"key":"1822_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","volume":"15","author":"SS Neelapu","year":"2018","unstructured":"Neelapu SS, Tummala S, Kebriaei P, Wierda W, Gutierrez C, Locke FL, et al. Chimeric antigen receptor T-cell therapy - assessment and management of toxicities. Nat Rev Clin Oncol. 2018;15:47\u201362.","journal-title":"Nat Rev Clin Oncol"},{"key":"1822_CR3","doi-asserted-by":"publisher","unstructured":"Li Y-R, Zhu Y, Halladay T, Yang L. In vivo CAR engineering for immunotherapy. Nat Rev Immunol. 2025;25:725\u201344. https:\/\/doi.org\/10.1038\/s41577-025-01174-1.","DOI":"10.1038\/s41577-025-01174-1"},{"key":"1822_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41573-020-0079-3","volume":"20","author":"LA Low","year":"2021","unstructured":"Low LA, Mummery C, Berridge BR, Austin CP, Tagle DA. Organs-on-chips: into the next decade. Nat Rev Drug Discov. 2021;20:345\u201361.","journal-title":"Nat Rev Drug Discov"},{"key":"1822_CR5","doi-asserted-by":"publisher","first-page":"e1005991","DOI":"10.1371\/journal.pcbi.1005991","volume":"14","author":"A Ghaffarizadeh","year":"2018","unstructured":"Ghaffarizadeh A, Heiland R, Friedman SH, Mumenthaler SM, Macklin P, PhysiCell. An open source physics-based cell simulator for 3-D multicellular systems. PLoS Comput Biol. 2018;14:e1005991.","journal-title":"PLoS Comput Biol"},{"key":"1822_CR6","doi-asserted-by":"publisher","first-page":"eabg6986","DOI":"10.1126\/scitranslmed.abg6986","volume":"13","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Hresko ME, Picton LK, Su L, Hollander MJ, Nunez-Cruz S, et al. A human orthogonal IL-2 and IL-2R\u03b2 system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia. Sci Transl Med. 2021;13:eabg6986.","journal-title":"Sci Transl Med"},{"key":"1822_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nbt.4086","volume":"36","author":"K Adachi","year":"2018","unstructured":"Adachi K, Kano Y, Nagai T, Okuyama N, Sakoda Y, Tamada K. IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor. Nat Biotechnol. 2018;36:346\u201351.","journal-title":"Nat Biotechnol"},{"key":"1822_CR8","doi-asserted-by":"publisher","unstructured":"Li Y-R, Zhu Y, Yang L. IL-15 in CAR engineering: striking an efficacy-safety balance. Trends Mol Med. 2025;31(11):977\u201381. https:\/\/doi.org\/10.1016\/j.molmed.2025.05.014.","DOI":"10.1016\/j.molmed.2025.05.014"},{"key":"1822_CR9","doi-asserted-by":"publisher","unstructured":"Li Y-R, Zhu Y, Yang L. IL-18 revives dysfunctional CAR-T cells. Trends Cancer. 2025;11(10):923\u201326. https:\/\/doi.org\/10.1016\/j.trecan.2025.06.008.","DOI":"10.1016\/j.trecan.2025.06.008"},{"key":"1822_CR10","doi-asserted-by":"publisher","unstructured":"Prasad K, Cross RS, Jenkins MR. Progress in the development of cytokine armoured CAR T cells. Nat Rev Immunol. 2026. https:\/\/doi.org\/10.1038\/s41577-026-01280-8.","DOI":"10.1038\/s41577-026-01280-8"},{"key":"1822_CR11","doi-asserted-by":"publisher","first-page":"1135468","DOI":"10.3389\/fmed.2023.1135468","volume":"10","author":"Y Chen","year":"2023","unstructured":"Chen Y, Zhu Y, Kramer A, Fang Y, Wilson M, Li Y-R, et al. Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy. Front Med. 2023;10:1135468.","journal-title":"Front Med"},{"key":"1822_CR12","doi-asserted-by":"publisher","unstructured":"Steffin D, Ghatwai N, Montalbano A, Rathi P, Courtney AN, Arnett AB et al. Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers. Nature. 2025;637(8047):940\u20136. https:\/\/doi.org\/10.1038\/s41586-024-08261-8.","DOI":"10.1038\/s41586-024-08261-8"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01822-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-026-01822-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01822-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T19:24:25Z","timestamp":1782933865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13045-026-01822-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1822"],"URL":"https:\/\/doi.org\/10.1186\/s13045-026-01822-6","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal studies were conducted under protocols approved by the UCLA Division of Laboratory Animal Medicine. Healthy donor PBMCs were obtained from the UCLA\/CFAR Virology Core Laboratory and HemaCare under informed consent and in compliance with federal and state regulations; no identifying information was provided.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}